Why people ask
BPC-157 was first described as a fragment of a protein found in gastric juice, and supporters say it is unusually stable in the stomach. That is why capsules, tablets and oral sprays are sold alongside injections. Stability in a test tube or in rat stomachs is not the same as proof that a capsule delivers an effective amount into a person’s bloodstream.
What the research shows for each route
| Oral (capsule, tablet, drinking water in animal studies) | Injection | |
|---|---|---|
| Animal studies | Yes, mostly rats, especially for gut injury models | Yes, rats and other animals, across many tissue models |
| Absorption measured | Not in people | In rats and dogs: short half-life (under 30 minutes) after injection into muscle or vein |
| Human data | None published that we found | A few small, uncontrolled reports, including injections into the knee and an IV safety pilot |
| FDA-approved | No | No |
Which is safer?
Neither route has been shown to be safe in people, because neither has been tested in large human studies. FDA has raised concerns about immune reactions and impurities for BPC-157. With an injection, sterile preparation matters, which is one reason a licensed compounding pharmacy and a clinician review are part of the Peps RX process. Capsules sold online as supplements are not reviewed for identity or content.
What to ask a clinician
- Is BPC-157 appropriate for my situation at all, or is there a better-studied option?
- What do my other conditions, including any cancer history, mean for this decision?
- Which pharmacy prepares it, and what does the label state?
For the full evidence picture, read BPC-157 evidence and safety.